Real Credentials Documented Reviews No Invented Endorsements

Medical Reviewer Standards

This page explains the qualifications and transparency expected of a healthcare professional who reviews SemaGLP medical content. It is a description of reviewer responsibilities—not a profile of an imaginary doctor, a representation that a specific clinician has signed off on all articles, or a substitute for an individualized consultation.

Last updated: October 19, 2026

What a Medical Reviewer Does

An appropriate medical reviewer assesses whether medication claims convey accurate clinical meaning, not merely whether a citation is present. The reviewer may examine contraindications, labeled populations, trial findings, clinically significant omissions and whether language could encourage unsafe medicine changes.

A reviewer is not the treating clinician of website visitors and cannot select a prescription for them through a published review credit.

Identity Must Be Real and Verifiable

SemaGLP does not invent physician identities, display generic credentials as proof of an individual review or treat a decorative medical badge as verified expertise. A named reviewer should be a real person who has agreed to be identified and whose claimed professional qualifications can be checked independently.

Until a specific qualified professional has actually performed and authorized review of a page, SemaGLP should not label that page “medically reviewed by” a person. This policy does not list a fictional stand-in.

Qualifications Should Match the Content

Relevant professional expertise might include clinical pharmacy, endocrinology, diabetes care, obesity medicine or other fields suited to the claim. A pharmacist may be well placed to assess labeling, interactions and dispensing; an appropriately qualified medical clinician may review patient-population and trial interpretation.

Credentials should be pertinent, current and accurately described. An academic degree, professional license and specialty certification are not the same assertion, and any of them may require independent verification.

Evidence for Reviewer Qualifications
Claim Supporting record Why it matters
Physician or pharmacist licenseApplicable official licensing boardSupports professional standing where current
Clinical specialtyVerifiable certification or trainingShows relevance to the article topic
Institutional affiliationCurrent authorized institutional biographyHistorical jobs are not current endorsements
Completed reviewPage-specific review date, version and sign-offAvoids invented medical-review badges
Potential conflictsRelevant financial and professional disclosuresSupports interpretation of independence

How Qualifications Can Be Verified

Where a specific reviewer is named, appropriate checks may include state medical or pharmacy licensing registers, recognized certification bodies, institutional professional listings and documented scope of expertise. A historical biography is not by itself evidence of current unrestricted licensure.

A professional’s photo, institution name or work history must not be reproduced without a proper basis, and unrelated expertise should not be presented as a guarantee of competence in every metabolic or weight-management topic.

Review Scope and Sign-Off

A meaningful review record should identify the version or publication date of the article, relevant sections checked, reviewer name where attributed, date of actual review and whether conclusions required corrections. Material edits to the content may make a prior review date insufficient.

A reviewer may recommend narrower statements, updated sources, better distinction between formulations or clarification of safety warnings. The editorial team remains responsible for implementing and accurately describing changes.

Semaglutide-Specific Review Priorities

Among the issues requiring especially careful treatment are the FDA-labeled distinction between Ozempic and Wegovy, oral versus injection administration, boxed warnings, pregnancy-related precautions, other therapies, differences between approved and compounded drugs, and the patient groups in direct trials.

Reviewer oversight should not imply that a foreign product or an unofficial seller is safe or FDA-approved. Nor should a trial percentage be treated as proof of the outcome for any individual visitor.

Recognizing the Limits of FDA and Commercial Records

An FDA application supports specified product authorization; a label establishes intended uses and warnings; clinical studies support specified outcomes; a manufacturer press release may identify a launch or supply arrangement. None of these records by itself verifies the credentials of a medical reviewer.

Likewise a reviewer’s contribution is not certification of a pharmacy, insurance reimbursement, current medicine inventory or third-party services.

Conflicts of Interest and Independence

Where a reviewer has a relationship with a manufacturer, pharmacy, advertiser or other organization that could be relevant to the reviewed subject, the relationship should be evaluated and disclosed where appropriate. A paid affiliation is not proof of wrongdoing, but the nature of the relationship must not be hidden in a way that misleads readers.

Independent medical interpretation and clear attribution should take precedence over promotional claims or desired conversion outcomes.

How Our Process and Reviewer Standards Relate

The Medical Review Process describes which statements need scrutiny and how documentation and corrections fit together. This page is about identifying and attributing real professionals rather than implying that a clinical-signoff service has been provided to every article.

General SemaGLP articles also receive editorial and regulatory checking as appropriate, but source verification should not be relabeled as individual medical approval.

Report Incorrect Review Attribution

Please use Contact SemaGLP if you find a false medical-review claim, outdated credential or unsubstantiated professional endorsement on this website. Include the page URL and the specific statement; no private medical information is needed.

SemaGLP evaluates supported reports but cannot provide personalized clinical assessments through the correction channel.